Moe Alsumidaie


New Compliance Issues Emerge Amidst COVID Clinical Operations

October 20, 2020

A discussion of the forces currently impacting global operations, FDA foresight on operating clinical studies during COVID, and the subsequent compliance issues manifesting from poorly executed decentralized clinical trial operations.

COVID Shifts Clinical Innovation in Big Pharma

October 16, 2020

Hassan Kadhim, Director, Global Head of Clinical Trial Business Capabilities, Clinical Innovation & Industry Collaborations at Bristol Myers Squibb, discusses his perspectives on how the pandemic has shifted clinical innovation.